DeAngelo DJ, Jonas BA, Liesveld JL, Bixby DL, et al. Phase 1/2 study of uproleselan added to chemotherapy in patients with relapsed or refractory acute myeloid leukemia. Blood 2021 Sep 20. pii: 476977. doi: 10.1182/blood.2021010721.
PMID: 34543383